Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375089 · ClinicalTrials.gov registry record
Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 392
- Enrollment target
NCT00375089: Completed study, sponsored by University of Florida.
NCT00375089 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 392 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00375089 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 392 participants
- Enrollment target
Study Summary
Prader-Willi syndrome (PWS) is a rare genetic disorder that affects about 1 in 14,000 people in the United States. As the most commonly identified genetic cause of obesity, PWS is often confused with Early-onset Morbid Obesity (EMO). Individuals with EMO show some signs of PWS, but clinically do not have PWS. The purpose of this study is to evaluate the clinical features and genetic basis of PWS and EMO, and to determine how these conditions affect a person throughout a lifetime.
Primary Outcome
phenotypic assessments will include cognitive level, behavioral analysis, physical features including body measurements and composition, co-morbidities (skin picking, psychiatric history, seizures, autistic behavior) medications required, and further comparison with the underlying molecular diagnosis.
Interventions
- OTHER Group 1
- OTHER Group 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2006-09 |
| Est. Completion | 2014-01 |
What the finished NCT00375089 record still lists
NCT00375089 is an observational study that tracks outcomes without assigning an intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Group 1 is the first listed.
NCT00375089 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00375089 about?
NCT00375089 is a clinical study titled "Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity". Prader-Willi syndrome (PWS) is a rare genetic disorder that affects about 1 in 14,000 people in the United States. As the most commonly identified genetic cause of obesity, PWS is often confused with Early-onset Morbid Obesity (EMO). Individuals with EMO show some signs of PWS, but clinically do not...
What is the current status of trial NCT00375089?
This trial is currently completed. The enrollment target is 392 participants. The study started on 2006-09. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00375089?
The interventions under investigation include: Group 1 (OTHER), Group 2 (OTHER).
Who is sponsoring clinical trial NCT00375089?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia